Icon Arrays Reduce Concern Over COVID-19 Vaccine Side Effects: A Randomized Control Study

2021 ◽  
Author(s):  
Madison Fansher ◽  
Tyler James Adkins ◽  
Poortata Lalwani ◽  
Aysecan Boduroglu ◽  
Madison Carlson ◽  
...  
Keyword(s):  
Side Effects ◽  
Best Practices ◽  
Side Effect ◽  
Blood Clotting ◽  
Vaccine Hesitancy ◽  
Main Concern ◽  
The Public ◽  
Randomized Control ◽  
Control Study ◽  
Icon Arrays

On April 13, 2021, the CDC announced that the administration of Johnson and Johnson’s COVID-19 vaccine would be paused due to a rare blood clotting side effect in ~0.0001% of people given the vaccine. Most people who are hesitant to get a COVID-19 vaccine list potential side effects as their main concern (PEW, 2021); thus, it is likely that this announcement increased vaccine hesitancy among the American public. Two days after the CDC’s announcement, we administered a survey to a group of 2,046 Americans to assess their attitudes toward COVID-19 vaccines. The aim of this study was to investigate best practices for communicating information about the risk of side effects to the public. We found that the use of icon arrays to illustrate the small chance of experiencing the blood clotting side effect greatly decreased reported aversion toward the Johnson and Johnson vaccine as well as all other COVID-19 vaccines.

The Impact of Prescribed Medication on Swallowing: An Overview

2010 ◽  
Vol 19 (4) ◽  
pp. 98-102 ◽  
Author(s):  
Louise Gallagher
Keyword(s):  
Side Effects ◽  
Best Practices ◽  
Side Effect ◽  
Team Member ◽  
Assessment Process ◽  
Valuable Resource ◽  
Speech Language Pathologists ◽  
Swallowing Difficulties ◽  
The Impact

Dysphagia clinicians are aware that best practices guidelines recommend a medications review as part of the assessment process. This article aims to review the literature to date regarding the impact that medications may have on the physiology of swallowing. It is important to consider the side effects of all medications, not only medications listing swallowing difficulties as a known side effect. Medications that impact upon arousal, awareness, and xerostomia should also be considered as part of a comprehensive dysphagia evaluation. Speech-language pathologists should consider the pharmacist an integral dysphagia team member and a valuable resource.

COVID 19 vaccine in patients of hypercoagulable disorders: a clinical perspective

2021 ◽  
Vol 0 (0) ◽  
Author(s):  
Nitin Ashok John ◽  
Jyoti John ◽  
Praful Kamble ◽  
Anish Singhal ◽  
Vandana Daulatabad ◽  
...  
Keyword(s):  
Side Effects ◽  
Side Effect ◽  
Vascular Endothelial Cell ◽  
Blood Stasis ◽  
Vascular Endothelial ◽  
The Public ◽  
Care Workers ◽  
Review Management ◽  
Rare Side Effect ◽  
To Receive

Abstract COVID 19 is an infectious disease caused by severe acute respiratory syndrome corona virus 2. Thromboembolism has been a characteristic manifestation in most of the severely ill COVID-19 patients. Thromboembolism in COVID 19 infection is attributed to injury to the vascular endothelial cell, hypercoagulability and blood stasis. The hypercoagulable state of blood and thrombophilic diseases leads to hypercoagulability. COVID 19 infected patients with pre-existing hypercoagulable disorders have higher risk of developing thrombosis and thromboembolism and such thrombotic episodes may prove to be severely morbid in these patients. As immune-prophylaxis COVID 19 vaccines are being administered to the public. The known side effects of the COVID 19 vaccine are mild to moderate and include fever, chills, nausea, vomiting, headache, fatigue, myalgia, malaise, pain and swelling at injection site and diarrhea. Thrombosis with thrombocytopenia has been noted as a rare side effect of COVID 19 vaccine. Such side effect of COVID 19 vaccine in patients of hypercoagulable disorder may prove to be fatal. The health care workers should be cautious and judicious in managing such patients. A detailed lab profile for coagulable state of blood should be carried out in all patients COVID 19 infected patients with pre-existing hypercoagulability diseases. The patients should also be health educated regarding side effects of vaccine especially with those indicating thrombosis and they should be warranted to receive immediate medical care in case of any side effects or complications. Paucity of literature gave us an impetus to review management profile in patients of hypercoagulable disorders.

scholarly journals With Great Hopes Come Great Expectations: Access and Adoption Issues Associated With COVID-19 Vaccines (Preprint)

2020 ◽  
Author(s):  
Zhaohui Su ◽  
Dean McDonnell ◽  
Ali Cheshmehzangi ◽  
Xiaoshan Li ◽  
Daniel Maestro ◽  
...  
Keyword(s):  
Health Care ◽  
Side Effects ◽  
Health Care Professionals ◽  
Vaccine Efficacy ◽  
Vaccine Hesitancy ◽  
Government Officials ◽  
Great Expectations ◽  
The Public ◽  
Accessibility Issues ◽  
Health Experts

UNSTRUCTURED Although COVID-19 vaccines are becoming increasingly available, their ability to effectively control and contain the spread of the COVID-19 pandemic is highly contingent on an array of factors. This paper discusses how limitations to vaccine accessibility, issues associated with vaccine side effects, concerns regarding vaccine efficacy, along with the persistent prevalence of vaccine hesitancy among the public, including health care professionals, might impact the potential of COVID-19 vaccines to curb the pandemic. We draw insights from the literature to identify practical solutions that could boost people’s adoption of COVID-19 vaccines and their accessibility. We conclude with a discussion on health experts’ and government officials’ moral and ethical responsibilities to the public, even in light of the urgency to adopt and endorse “the greatest amount of good for the greatest number” utilitarian philosophy in controlling and managing the spread of COVID-19.

A Study to assess side effects of first dose of Covid-19 Vaccination among GNM students studying at JSS School of Nursing Chamarajanagar

2021 ◽  
pp. 552-554
Author(s):  
Usha N S ◽  
Sushmitha H S ◽  
Vinay Kumar G
Keyword(s):  
Side Effects ◽  
Disease Spread ◽  
Vaccine Hesitancy ◽  
Mild Form ◽  
Protective Efficiency ◽  
Post Vaccination ◽  
The Public ◽  
School Of Nursing ◽  
The World ◽  
Mild Fever

Background: The world is in the midst of a COVID-19 Pandemic. While countries, including India, have taken strong measures to control the spread of COVID-19 through better diagnostics and treatment. Vaccines will provide a lasting solution by enhancing Immunity and containing the disease spread. COVID-19 vaccine has been rolled out recently in several parts of the world. Although the protective efficiency is frequently discussed, little is known about the real-world post-vaccination experience outside of clinical trial conditions. Knowledge about what to expect after vaccination will help educate the public, dispel misinformation and reduce vaccine hesitancy. Objectives: To assess the immediate response to the first dose of Covid- 19 vaccine and to study the side effects of Covid- 19 vaccination. Results: Results of the study revealed that 143(95.3%) participants are not developed any side effects, only 7 (4.66%) participants reported mild side effects within 30 minutes after vaccination, 104 (69.33%) participants are developed mild side effects like fever, body pain after 30 minutes to 24 hours, 14 (9.33%) participants are developed side effects in mild form after 24 hours, only 2(1.33%) participants are developed side effects like mild fever and fatigue after 1 week of vaccination, majority of the participants 149 (99.33%) didn't required any hospitalization and only 1 participant (0.66% ) admitted to hospital due to fever for one day, majority of participants 63 (42%) are recovered from side effects within 24 hours, 28 (18.66%) participants are recovered within 2 to 8 hours, 14 (9.3%) participants are recovered within 2 hours, 4 (2.66%)participants are recovered within 8 to 24hours and 41 (27.3%) participants are recovered after 24 hours. All the participants are willing to take 2nd dose and recommend for their family members and friends to get vaccination.

scholarly journals International attitudes on COVID-19 vaccination: repeat national cross-sectional surveys across 15 countries

2021 ◽  
Author(s):  
Roberto Fernandez Crespo ◽  
Manar Shafat ◽  
Natalie Melas-Kyriazi ◽  
Lisa J Gould ◽  
Sarah Jones ◽  
...  
Keyword(s):  
Side Effects ◽  
Vaccine Hesitancy ◽  
Cross Sectional ◽  
Younger Adults ◽  
The Public ◽  
The United Kingdom ◽  
Outcomes Measures ◽  
Short Time ◽  
To Receive ◽  
At Home

Objective: To examine the general publics views around willingness to receive COVID-19 vaccines and concerns regarding their safety. Design: Repeat cross-sectional surveys. Setting: Online surveys in Australia, Canada, Denmark, Finland, France, Germany, Italy, Japan, Netherlands, Norway, Singapore, South Korea, Spain, Sweden and the United Kingdom Participants: National samples of adults aged 18 years and above in November 2020 and January 2021. Main outcomes measures: The proportion of adults reporting: willingness to receive a COVID-19 vaccination; concern regarding side-effects from vaccinations; concerns over contraction COVID-19, and beliefs around vaccine provision in their country. Changes between the November and January surveys are also reported. Results: Across the 15 countries, the proportion of respondents reporting they would have the COVID-19 vaccine increased from 40.7% (range: 25.0-55.1) to 55.2% (range: 34.8-77.5), proportion reporting worried about the side-effects of vaccine decreased from 53.3% (range: 42.1-66.7) to 47.9% (range: 28.0-66.1). On the second survey, willingness to receive vaccine remained low in females (49.4%, range: 30.2-79.1), aged 18-39 years (42.1%, range: 25.9-71.7), those not working or unemployed (48.9, range: 18.8-67.0), students (45.9%, range: 22.8-70.0), and those with children at home (46.5%, range: 32.4-68.9). Concerns regarding safety of vaccine remained high in females (53.7%, range: 31.8-70.4), aged 18-39 years (50.8%, range: 28.2-60.7), aged 40-64 years (51.3%, range: 30.7-68.5), those working (50.5%, range: 26.7-65.0), those not working or unemployed (53.3, range: 35.4-73.8) and those with children at home (55.8%, range: 36.5-64.7). Conclusion: COVID-19 vaccine hesitancy decreased considerably over a relatively short time coinciding with the discovery of effective vaccines. The public remain concerned about their safety, and public health messaging will need to emphasis their safety especially amongst females, parents and younger adults.

scholarly journals PERCEPTION OF SUPERVISOR TAKING MEDICINE ABOUT THE SIDE EFFECT OF TUBERCULOSIS MEDICATION FOR PATIENTS

2018 ◽  
Vol 5 (1) ◽  
pp. 058-061
Author(s):  
Suprajitno Suprajitno ◽  
Imam Sunarno ◽  
Oky Aditya Ardiansah
Keyword(s):  
Side Effects ◽  
Side Effect ◽  
Health Workers ◽  
Term Treatment ◽  
Short Term Treatment ◽  
The Public ◽  
Tb Treatment ◽  
Medication Side Effect ◽  
Medication Side ◽  
The Right

DOTS strategy is a short-term treatment guide with direct supervision by supervisor taking medicine for tuberculosis patients. Supervisors should know, understand, and be able to distinguish between mild and severe side effects of anti-tuberculosis drugs. The failure of Tb treatment depends on supervisor taking medicine. Currently, never been known the perception of supervisor taking medicine about tuberculosis medication side effect. The purpose of the research was to know the perception of the supervisor taking medicine about side effects for clients’ Tb treatment program in Blitar City. The research design used a descriptive. The result showed the perception of supervisor taking medicine about the side effects was as much as 54.5% in the right category and as much as 45.5% in the wrong category. The right category perception may be the supervisor taking medicine ever receive information of tuberculosis medication side effect at the public health center while take a drug. Recommendations for health workers are providing appropriate information to the supervisor taking medicine can be improved with technique of counseling and training so it can improve knowledge and expertise in the management of medication side effects.Key words: perceptions, supervisor taking medicine, Tuberculosis

scholarly journals Correlation between Perceived Fear of COVID-19 Infection and Demand for COVID-19 Vaccination in Thailand: A Cross Sectional Study

2021 ◽  
Vol 6 (3) ◽  
pp. 345-349
Author(s):  
Sompoom Sunpaweravong
Keyword(s):  
Side Effects ◽  
Cross Sectional Study ◽  
Lifestyle Changes ◽  
Vaccine Hesitancy ◽  
Cross Sectional ◽  
Socioeconomic Impacts ◽  
The Public ◽  
Risk Of Death ◽  
Blood Clots ◽  
Underlying Diseases

As the global COVID-19 pandemic became increasingly severe, the perceived fear of infection amongst the general population increased significantly. Many aspects of COVID-19 infection such as the ailment’s severe symptoms and risk of death contributed greatly to the collective fear surrounding this disease. The fear of infection resulted in lifestyle changes for many which in turn caused a great extent of socioeconomic impacts on both the regional and global level. Correlating closely to the fear of infection, vaccine related fear became a growing trend amongst the public. The majority of those fearing the vaccines were skeptical of its safety and risk of severe although rare side effects such as blood clots or convulsion not to mention the more common side effects such as high fevers that deterred a significant portion of the population from getting vaccinated. With these two closely related fears causing great effects on our society, our study decided to study the correlation and interaction between these two metrics. Through measuring both COVID-19 infection and vaccination fear of 351 subjects from diverse demographics, our study found many correlations between the perceived fear for COVID 19 infection, demand and reluctance for COVID 19 vaccination and other factors such as the age of the subject. Our study also took various measurements regarding the subjects involved in this study such as the subject’s age and underlying diseases that are known to augment the severity of COVID-19 symptoms such as Diabetes, underlying heart disease and lung diseases. After rigorous data analysis, the study found proportionate correlations between the levels of perceived fear of COVID-19 infection and the demand for vaccination. The demographics of participants (age and underlying diseases) were also found to have a correlative effect on the former measurements. Keywords: COVID-19 fear, vaccine hesitancy, COVID-19 risk factors.

scholarly journals Covid-19 vaccine perceptions in Senegal and in Mali: a mixed approach

2021 ◽  
Author(s):  
Eleonore Fournier-Tombs ◽  
Massamba Diouf ◽  
Abdine Maiga ◽  
Sylvain Faye ◽  
Tidiane Ndoye ◽  
...  
Keyword(s):  
Public Health ◽  
Artificial Intelligence ◽  
Chronic Disease ◽  
Side Effects ◽  
Public Health System ◽  
Vaccine Hesitancy ◽  
Male And Female ◽  
The Public ◽  
The Family ◽  
Mixed Approach

AbstractThis paper presents the results of two qualitative surveys in Senegal and in Mali, which include questions about hesitancy to the COVID-19 vaccine between April and June 2021. It took place within a larger 2-year research project involving researchers in Senegal, Mali and Canada which examines the uses of artificial intelligence technologies in the fight against COVID-19. The study involved 1000 respondents in Senegal and 555 in Mali. The researchers found that overall, 55% of respondents in Senegal and 52% of respondents in Mali did not plan to be vaccinated. Hesitancy was much higher in youth aged 15-35 in both cases, with 70% of youth in Senegal and 57% of youth in Mali not planning to be vaccinated, compared to only 42% of elderly in Senegal and 37% of elderly in Mali. The researchers did not find disparities between male and female respondents in Senegal but found some in Mali. They also found that those who had a member of the family with chronic disease (diabetes or hypertension) were slightly more likely to want to be vaccinated. Reasons for vaccine hesitancy fell in several categories, including fear of vaccine side-effects, disbelief in vaccine efficacy or usefulness, and general distrust in the public health system.

Hypercoagulabilité Sanguine avec Administration de Noréthynodrel : Correction par Purification de la Progestine

1973 ◽  
Vol 51 (7) ◽  
pp. 555-558
Author(s):  
P. Brazeau ◽  
M. Dansereau ◽  
M. H. Gervais ◽  
R. C. Banerjee
Keyword(s):  
Side Effects ◽  
Adult Female ◽  
Oral Contraceptives ◽  
Side Effect ◽  
Blood Clotting ◽  
Degradation Products ◽  
Female Rats ◽  
Female Rat ◽  
The Times

Blood clotting induced by non-purified norethynodrel is no longer observed in adult female rats when purified norethynodrel (99.7% pure) is used. Analysis of the times of bleeding and of coagulation of these rats treated with purified and non-purified norethynodrel clearly demonstrate that the purification of progestin eliminates the thromboembolic side effects. It is debated whether or not the concentration of estrogens can fully explain these side effects associated with the use of oral contraceptives. Furthermore, degradation products and/or contaminants during synthesis of this progestin would be, in large part, responsible for this blood clotting side effect in the female rat.

Cutaneous ulcers following hydroxyurea therapy

Phlebologie ◽  
2004 ◽  
Vol 33 (06) ◽  
pp. 202-205 ◽  
Author(s):  
K. Hartmann ◽  
S. Nagel ◽  
T. Erichsen ◽  
E. Rabe ◽  
K. H. Grips ◽  
...  
Keyword(s):  
Side Effects ◽  
Side Effect ◽  
Antineoplastic Agent ◽  
Limited Time ◽  
Myeloproliferative Diseases ◽  
Dermatological Side Effects ◽  
Chronic Myeloproliferative Diseases ◽  
Hydroxyurea Therapy

SummaryHydroxyurea (HU) is usually a well tolerated antineoplastic agent and is commonly used in the treatment of chronic myeloproliferative diseases. Dermatological side effects are frequently seen in patients receiving longterm HU therapy. Cutaneous ulcers have been reported occasionally.We report on four patients with cutaneous ulcers whilst on long-term hydroxyurea therapy for myeloproliferative diseases. In all patients we were able to reduce the dose, or stop HU altogether and their ulcers markedly improved. Our observations suggest that cutaneous ulcers should be considered as possible side effect of long-term HU therapy and healing of the ulcers can be achieved not only by cessation of the HU treatment, but also by reducing the dose of hydroxyurea for a limited time.

Sign in / Sign up

Export Citation Format

Share Document